GH
Gwenn Hansen
DELAYED 1 MONTH
Chief Scientific Officer
Nurix Therapeutics, Inc.
Filings
2
Companies
1
Latest
Jul 30, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
60
NRIXCLUSTER 3
Nurix Therapeutics, Inc.
Gwenn Hansen
Chief Scientific Officer
Sale
$90.0K
3,847 sh
Jul 30 9:50 PM
Jul 30, 2026
—
Nurix Therapeutics, Inc.
Gwenn Hansen
Chief Scientific Officer
Option Exercise
—
10,180 sh
Jul 30 9:50 PM
Jul 30, 2026
60
NRIXCLUSTER 3
Nurix Therapeutics, Inc.
Gwenn Hansen
Chief Scientific Officer
Sale
$53.5K
3,214 sh
Apr 30 9:35 PM
Apr 30, 2026
—
Nurix Therapeutics, Inc.
Gwenn Hansen
Chief Scientific Officer
Option Exercise
—
8,608 sh
Apr 30 9:35 PM
Apr 30, 2026